151 related articles for article (PubMed ID: 24497183)
21. Liver Disease and Risk of Hepatocellular Carcinoma in Children With Mutations in TALDO1.
Grammatikopoulos T; Hadzic N; Foskett P; Strautnieks S; Samyn M; Vara R; Dhawan A; Hertecant J; Al Jasmi F; Rahman O; Deheragoda M; Bull LN; Thompson RJ;
Hepatol Commun; 2022 Mar; 6(3):473-479. PubMed ID: 34677006
[TBL] [Abstract][Full Text] [Related]
22. Novel heterozygous mutations in TALDO1 gene causing transaldolase deficiency and early infantile liver failure.
Balasubramaniam S; Wamelink MM; Ngu LH; Talib A; Salomons GS; Jakobs C; Keng WT
J Pediatr Gastroenterol Nutr; 2011 Jan; 52(1):113-6. PubMed ID: 21119539
[No Abstract] [Full Text] [Related]
23. Transaldolase Deficiency: A New Case Expands the Phenotypic Spectrum.
Banne E; Meiner V; Shaag A; Katz-Brull R; Gamliel A; Korman S; Cederboim SH; Duvdevani MP; Frumkin A; Zilkha A; Kapuller V; Arbell D; Cohen E; Eventov-Friedman S
JIMD Rep; 2016; 26():31-6. PubMed ID: 26238251
[TBL] [Abstract][Full Text] [Related]
24. Transaldolase deficiency influences the pentose phosphate pathway, mitochondrial homoeostasis and apoptosis signal processing.
Qian Y; Banerjee S; Grossman CE; Amidon W; Nagy G; Barcza M; Niland B; Karp DR; Middleton FA; Banki K; Perl A
Biochem J; 2008 Oct; 415(1):123-34. PubMed ID: 18498245
[TBL] [Abstract][Full Text] [Related]
25. Transaldolase haploinsufficiency in subjects with acetaminophen-induced liver failure.
Oaks Z; Jimah J; Grossman CC; Beckford M; Kelly R; Banerjee S; Niland B; Miklossy G; Kuloglu Z; Kansu A; Lee W; Szonyi L; Banki K; Perl A
J Inherit Metab Dis; 2020 May; 43(3):496-506. PubMed ID: 31769880
[TBL] [Abstract][Full Text] [Related]
26. Quantification of sugar phosphate intermediates of the pentose phosphate pathway by LC-MS/MS: application to two new inherited defects of metabolism.
Wamelink MM; Struys EA; Huck JH; Roos B; van der Knaap MS; Jakobs C; Verhoeven NM
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 823(1):18-25. PubMed ID: 16055050
[TBL] [Abstract][Full Text] [Related]
27. The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review.
Wamelink MM; Struys EA; Jakobs C
J Inherit Metab Dis; 2008 Dec; 31(6):703-17. PubMed ID: 18987987
[TBL] [Abstract][Full Text] [Related]
28. Study of transaldolase deficiency in urine samples by capillary LC-MS/MS.
Vas G; Conkrite K; Amidon W; Qian Y; Bánki K; Perl A
J Mass Spectrom; 2006 Apr; 41(4):463-9. PubMed ID: 16470722
[TBL] [Abstract][Full Text] [Related]
29. Apparent Acetaminophen Toxicity in a Patient with Transaldolase Deficiency.
Lee-Barber J; English TE; Britton JF; Sobreira N; Goldstein J; Valle D; Bjornsson HT
JIMD Rep; 2019; 44():9-15. PubMed ID: 29923087
[TBL] [Abstract][Full Text] [Related]
30. Late diagnosis of a rare multisystemic genetic disorder: Transaldolase deficiency due to homozygous TALDO1 c.345dupA variant.
Dirim AB; Kalayci T; Safak S; Garayeva Guller N; Oto OA; Artan AS; Ozturk S; Yazici H
Nephrology (Carlton); 2024 Jan; 29(1):55-56. PubMed ID: 37740560
[No Abstract] [Full Text] [Related]
31. Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy.
Huck JH; Verhoeven NM; Struys EA; Salomons GS; Jakobs C; van der Knaap MS
Am J Hum Genet; 2004 Apr; 74(4):745-51. PubMed ID: 14988808
[TBL] [Abstract][Full Text] [Related]
32. Prenatal Diagnosis of Fetus With Transaldolase Deficiency Identifies Compound Heterozygous Variants: A Case Report.
Xue J; Han J; Zhao X; Zhen L; Mei S; Hu Z; Li X
Front Genet; 2021; 12():752272. PubMed ID: 35186000
[TBL] [Abstract][Full Text] [Related]
33. Systemic lupus erythematosus in a girl with PTEN variant and transaldolase deficiency: a novel phenotype.
Al-Mayouf SM; AlTassan RS; AlOwain MA
Clin Rheumatol; 2020 Nov; 39(11):3511-3515. PubMed ID: 32506314
[TBL] [Abstract][Full Text] [Related]
34. Molecular analysis of the structural gene for yeast transaldolase.
Schaaff I; Hohmann S; Zimmermann FK
Eur J Biochem; 1990 Mar; 188(3):597-603. PubMed ID: 2185015
[TBL] [Abstract][Full Text] [Related]
35. N-Acetylcysteine Therapy in an Infant with Transaldolase Deficiency Is Well Tolerated and Associated with Normalization of Alpha Fetoprotein Levels.
Rodan LH; Berry GT
JIMD Rep; 2017; 31():73-77. PubMed ID: 27130472
[TBL] [Abstract][Full Text] [Related]
36. Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples.
Wang C; Guo K; Gao D; Kang X; Jiang K; Li Y; Sun L; Zhang S; Sun C; Liu X; Wu W; Yang P; Liu Y
Cancer Lett; 2011 Dec; 313(2):154-66. PubMed ID: 22023829
[TBL] [Abstract][Full Text] [Related]
37. Retrospective detection of transaldolase deficiency in amniotic fluid: implications for prenatal diagnosis.
Wamelink MM; Struys EA; Valayannopoulos V; Gonzales M; Saudubray JM; Jakobs C
Prenat Diagn; 2008 May; 28(5):460-2. PubMed ID: 18444224
[No Abstract] [Full Text] [Related]
38. Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine.
Hanczko R; Fernandez DR; Doherty E; Qian Y; Vas G; Niland B; Telarico T; Garba A; Banerjee S; Middleton FA; Barrett D; Barcza M; Banki K; Landas SK; Perl A
J Clin Invest; 2009 Jun; 119(6):1546-57. PubMed ID: 19436114
[TBL] [Abstract][Full Text] [Related]
39. The pathogenesis of transaldolase deficiency.
Perl A
IUBMB Life; 2007 Jun; 59(6):365-73. PubMed ID: 17613166
[TBL] [Abstract][Full Text] [Related]
40. Urinary excretion of pentose phosphate pathway-associated polyols in early postnatal life.
Koy A; Waldhaus A; Hammen HW; Wendel U; Mayatepek E; Schadewaldt P
Neonatology; 2009; 95(3):256-61. PubMed ID: 18987485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
